David Páez

2.3k total citations
75 papers, 1.3k citations indexed

About

David Páez is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, David Páez has authored 75 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 26 papers in Molecular Biology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in David Páez's work include Colorectal Cancer Treatments and Studies (35 papers), Genetic factors in colorectal cancer (18 papers) and Cancer Genomics and Diagnostics (14 papers). David Páez is often cited by papers focused on Colorectal Cancer Treatments and Studies (35 papers), Genetic factors in colorectal cancer (18 papers) and Cancer Genomics and Diagnostics (14 papers). David Páez collaborates with scholars based in Spain, United States and Italy. David Páez's co-authors include Melissa J. LaBonte, Juliana Salazar, Heinz‐Josef Lenz, Pierre Bohanes, Yan Ning, Montserrat Baiget, Wu Zhang, Ana Sebio, Fotios Loupakis and Dongyun Yang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

David Páez

70 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Páez Spain 20 828 559 292 265 211 75 1.3k
Ernesto Wasserman United States 17 812 1.0× 418 0.7× 358 1.2× 377 1.4× 141 0.7× 35 1.2k
Alain Gelibter Italy 22 974 1.2× 332 0.6× 574 2.0× 333 1.3× 193 0.9× 100 1.4k
A. Craig Lockhart United States 17 477 0.6× 522 0.9× 261 0.9× 234 0.9× 102 0.5× 49 1.0k
Dale R. Shepard United States 17 478 0.6× 419 0.7× 470 1.6× 258 1.0× 115 0.5× 75 1.2k
G. Deplanque France 23 1.3k 1.6× 633 1.1× 812 2.8× 542 2.0× 225 1.1× 77 2.3k
Stratigoula Sakellariou Greece 19 398 0.5× 480 0.9× 224 0.8× 245 0.9× 286 1.4× 77 1.3k
Bart Jacobs Netherlands 18 1.0k 1.3× 408 0.7× 459 1.6× 301 1.1× 144 0.7× 59 1.4k
Olaf Christensen United States 16 847 1.0× 542 1.0× 321 1.1× 110 0.4× 117 0.6× 25 1.5k
Chiara Pierantoni Italy 16 809 1.0× 340 0.6× 366 1.3× 245 0.9× 155 0.7× 40 1.3k
Chung-Tsen Hsueh United States 19 556 0.7× 416 0.7× 305 1.0× 200 0.8× 112 0.5× 55 1.2k

Countries citing papers authored by David Páez

Since Specialization
Citations

This map shows the geographic impact of David Páez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Páez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Páez more than expected).

Fields of papers citing papers by David Páez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Páez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Páez. The network helps show where David Páez may publish in the future.

Co-authorship network of co-authors of David Páez

This figure shows the co-authorship network connecting the top 25 collaborators of David Páez. A scholar is included among the top collaborators of David Páez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Páez. David Páez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayala, Francisco, et al.. (2025). Oncological needs in transgender patients. Clinical & Translational Oncology. 27(10). 3849–3859.
2.
Montagut, Clara, Joana Vidal, Vicente Alonso-Orduña, et al.. (2025). LBA33 Circulating tumor (ct) DNA-guided anti-EGFR rechallenge strategy in metastatic colorectal cancer (mCRC): Final results of the phase II randomized CITRIC trial. Annals of Oncology. 36. S1576–S1577.
3.
Gallardo, Alberto, Eric Voltà‐Durán, A.C. Virgili Manrique, et al.. (2025). A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation. International Journal of Nanomedicine. Volume 20. 2445–2460. 3 indexed citations
4.
Mirallas, Oriol, Diana Valbuena, Maria Serena Roca, et al.. (2023). 2144P The PRognostic Oncologic Plantology (PROP) website tool predicts 30-day mortality in hospitalized cancer patients on treatment. Annals of Oncology. 34. S1116–S1117. 2 indexed citations
5.
Montés, Ana Fernández, Élena Elez, Juan de la Haba-Rodríguez, et al.. (2023). Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology. Clinical & Translational Oncology. 26(1). 98–108. 1 indexed citations
6.
7.
García‐Carbonero, Rocio, Carles Pericay, Ana Fernández Montés, et al.. (2023). Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain. Clinical & Translational Oncology. 26(4). 864–871. 1 indexed citations
8.
Capdevila, Jaume, Ismael Macías, Ignacio Escobar, et al.. (2023). Atezolizumab plus tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal: TIRANUS (GEMCAD-2103) trial.. Journal of Clinical Oncology. 41(16_suppl). TPS3624–TPS3624.
9.
Alba‐Castellón, Lorena, Eloi Parladé, Eric Voltà‐Durán, et al.. (2023). Site-directed cysteine coupling of disulfide-containing non-antibody carrier proteins (THIOCAPs). Science China Materials. 66(10). 4109–4120. 1 indexed citations
10.
11.
Tarazona, Noelia, Vilma Pacheco-Barcía, Berta Obispo, et al.. (2022). Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section. Clinical & Translational Oncology. 25(3). 796–802. 2 indexed citations
12.
Capdevila, Jaume, David Páez, Carles Pericay, et al.. (2022). SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021). Clinical & Translational Oncology. 24(4). 646–657. 9 indexed citations
13.
Pacheco-Barcía, Vilma, Berta Obispo, David Páez, et al.. (2021). 1847P Professional standing of young medical oncologists in Spain during COVID-19 pandemic: A nationwide survey by the Spanish Society of Medical Oncology (SEOM) +MIR Section. Annals of Oncology. 32. S1245–S1246. 1 indexed citations
14.
15.
Salazar, Ramón, Daniel Azuara, José María Viéitez, et al.. (2017). ULTRA clinical trial: Prospective comparative clinical outcome analysis of three different RAS/BRAF sensitivity mutational cut-offs. A Phase II study of the Spanish TTD Group. Annals of Oncology. 28. v185–v186. 1 indexed citations
16.
Rodríguez‐Vicente, Ana E., Eva Lumbreras, Jesús María Hernández-Sánchez, et al.. (2016). Pharmacogenetics and pharmacogenomics as tools in cancer therapy. Drug Metabolism and Personalized Therapy. 31(1). 25–34. 20 indexed citations
17.
Ning, Yan, Melissa J. LaBonte, Wu Zhang, et al.. (2012). The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models. Molecular Cancer Therapeutics. 11(6). 1353–1364. 102 indexed citations
18.
Gerger, Armin, Anthony B. El-Khoueiry, Wu Zhang, et al.. (2011). Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 17(17). 5783–5792. 72 indexed citations
19.
Páez, David, Juliana Salazar, Laia Paré, et al.. (2011). Pharmacogenetic Study in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy: Polymorphisms in Thymidylate Synthase, Epidermal Growth Factor Receptor, GSTP1, and DNA Repair Genes. International Journal of Radiation Oncology*Biology*Physics. 81(5). 1319–1327. 20 indexed citations
20.
Páez, David, Laia Paré, Albert Altés, et al.. (2010). Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil. Journal of Cancer Research and Clinical Oncology. 136(11). 1681–1689. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ernesto Wasserman Breakdown of academic impact, for papers by Alain Gelibter Breakdown of academic impact, for papers by A. Craig Lockhart Breakdown of academic impact, for papers by Dale R. Shepard Breakdown of academic impact, for papers by G. Deplanque Breakdown of academic impact, for papers by Stratigoula Sakellariou Breakdown of academic impact, for papers by Bart Jacobs Breakdown of academic impact, for papers by Olaf Christensen Breakdown of academic impact, for papers by Chiara Pierantoni Breakdown of academic impact, for papers by Chung-Tsen Hsueh
Rankless by CCL
2026